by Canadian Olympians and was first recommended to elite athletes by the Canadian Sport Centre Calgary in 2003. Earlier this year, all of the Canadian Sport Centres decided to recommend it to their athletes to help keep them in top health in this particularly challenging flu season.
Canadian Sport Centre Calgary President Dale Henwood says, "This certification is an important achievement. It provides additional confirmation for athletes who regard COLD-FX as a key part of their health regimen." Afexa is providing COLD-FX to 1,500 athletes, coaches, trainers and support staff at sport centres in seven provinces where the country's elite athletes train, including those preparing for the 2010 Winter Games.
Olympic Gold Medalist Clara Hughes says, "Many of my teammates and I rely upon it. I've gone through dozens and dozens of tests since I started taking COLD-FX over six years ago, and each time they come back negative for banned substances. NSF Certification is just further confirmation that athletes can take it without having to worry."
COLD-FX will be the exclusive cold and flu remedy available at general stores within the Olympic and Paralympic Villages in Vancouver and Whistler. VANOC has arranged with Afexa to make COLD-FX available to close to 40,000 volunteers, staff and media during the 2010 Winter Games.
*American National Standards Institute
To view the entire news release, please visit http://www.nsf.org/info/press/index.asp?p_id=16889.
CONTACTS:
Greta Houlahan
NSF International
734-913-5723
houlahan@nsf.org
Warren Michaels
Afexa Life Sciences Inc.
780-432-0022
'/>"/>
SOURCE NSF International Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
Project Lifesaver International Receives Federal Assistance for the Missing Alzheimers Patient Assistance Program2.
RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products3.
UM receives grant to support graduate students in the family nurse practitioner program4.
Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)5.
CBM-US Receives $3 Million Grant To Fund HIV/AIDS Prevention and Care Efforts in Africa6.
Solos Endoscopy, Inc. Receives Purchase Order from One of the Major Healthcare Systems in Missouri7.
Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT-4068.
Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology9.
Childrens Hospital receives federal contract to study antibiotic use in children with UTIs10.
Emdeon Receives EHNAC Healthcare Network Re-accreditation11.
ARUP Laboratories Scientist Tanya Sandrock Receives NIH Grant to Search for Additional HIV Therapies